Home Biosimilar Antibodies Cytoskeletal Signaling Integrin Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3))
For research use only. Not for use in humans.

Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3))

Synonyms: C4G1; YM-337

Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.

Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3))

Quality Control

Batch: A306501 Purity: 99% Protein concentration: 6.062mg/ml Endotoxin Level: ＜1EU/mg
99

Specificity

Name Citation Integrin ILK Others
Cilengitide trifluoroacetate 70
A-205804 6
GLPG0187 1
GSK-3008348 HCl 0
Bexotegrast (PLN-74809) 0
Cilengitide (EMD 121974) 36
OSU-T315 1
TR-14035 0
Cyclo(RGDyK) TFA 14
SB273005 27
RGD peptide (Arg-Gly-Asp) 26
ILK-IN-3 0
RGD peptide (GRGDNP) 1 caspase-3
ATN-161 22
Cyclo(-RGDfK) TFA 13
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.
References

Product Details

CAS No. 339086-80-5
Isotype Human IgG1
Source CHO
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.